H0120: Section on Clinical Pharmacology and Therapeutics

COVID-19 in Children: Medication and Vaccine Dosing, Safety, and Regulatory Considerations

Saturday, October 8, 2022

9:00 AM – 12:00 PM US PDT

Location: Anaheim Convention Center, 303AB

CME: 2.75

Topic(s): Pharmacology

Sponsor(s): Section on Clinical Pharmacology and Therapeutics

View full agenda here

Rx (Pharmacology): 2.75

Surges in SARS-CoV-2 infections have placed unique challenges on children, families, and pediatric providers. Children need safe and effective therapies, including vaccines for prevention and medications for treatment of severe disease. This session will focus on pediatric considerations for dosing, safety, and regulatory approval for medications and vaccines targeting SARS-CoV-2.

Faculty(s)

Rachel G. Greenberg, MD, MB, MHS

Associate Professor of Pediatrics
Duke University; Duke Clinical Research Institute
Durham, North Carolina, United States

Slides
Mari M. Nakamura, MD, MPH

Medical Director, Antimicrobial Stewardship; Associate Physician & Assistant Professor in Pediatrics
Boston Children's Hospital/Harvard Medical School
Boston, Massachusetts, United States

Slides
Emmanuel B. Walter, MD, MPH

Professor of Pediatrics
Duke Human Vaccine Institute Duke University School of Medicine
Durham, North Carolina, United States

Slides